MetaCap

GE HealthCare Technologies Cash Flow Statement

NASDAQ: GEHCHealth CareMedical ElectronicsUSD

65.74+1.52 (+2.37%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

GE HealthCare Technologies free cash flow

In fiscal 2025, GE HealthCare Technologies generated $1.99 billion of operating cash flow and spent $482.0 million on capital expenditures. That left free cash flow of $1.50 billion, a free-cash-flow margin of 7.3% of revenue. Free cash flow was down 3.2% from the prior year's $1.55 billion.

GE HealthCare Technologies returned $264.0 million to shareholders: $64.0 million in dividends and $200.0 million in share repurchases, equal to 18% of free cash flow. Free cash flow covered dividend payments 23.5 times.

Summary generated from market data by MetaCap's automated system. Methodology

GE HealthCare Technologies cash flow statement (annual)

GE HealthCare Technologies annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31
Net Income2.15B2.05B1.61B1.97B2.29B
Net Income growth (YoY)+5.07%+27.01%-17.95%-14.22%—
Depreciation & Amortization287.00M268.00M248.00M228.00M225.00M
Stock-Based Compensation130.00M125.00M114.00M67.00M76.00M
Change in Working Capital-187.00M-110.00M-136.00M-14.00M-1.53B
Operating Cash Flow1.99B1.96B2.10B2.13B1.61B
Capital Expenditures-482.00M-401.00M-387.00M-310.00M-248.00M
Investing Cash Flow-1.05B-914.00M-558.00M-398.00M-1.76B
Dividends Paid-64.00M-55.00M-41.00M00
Share Repurchases-200.00M00——
Financing Cash Flow617.00M-573.00M-478.00M-822.00M-263.00M
Net Change in Cash1.62B387.00M1.05B890.00M-451.00M
Free Cash Flow1.50B1.55B1.71B1.82B1.36B

This table shows 5 annual periods of GE HealthCare Technologies's cash flow statement, from FY 2025 back to FY 2021, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GEHC's reporting calendar. What is a cash flow statement?

More financial data